Skip to content

Journaling and Addiction Recovery: Piloting Positive Recovery Journaling

Journaling and Addiction Recovery: Piloting Positive Recovery Journaling

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04458181
Acronym
PPJ
Enrollment
81
Registered
2020-07-07
Start date
2020-07-07
Completion date
2021-11-01
Last updated
2024-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Addiction

Brief summary

The main objective of this study is to pilot test the Positive Peer Journaling (PPJ) \[later renamed Positive Recovery Journaling (PRJ)\] intervention and its feasibility and acceptability. A second objective is to compare individuals assigned to PPJ to individuals in a treatment as usual control group.

Detailed description

Many spiritual and religious traditions involve the practice of personal inventory and self-examination. These practices involve conducting a review of the day, spirituality, gratitude, and striving for self-knowledge and self-improvement. The 10th step of Alcoholics Anonymous (AA) recommends that members conduct such a daily inventory. While this practice may benefit AA members, not everyone seeking addiction recovery joins AA. Even for those who do, it can take time to reach step 10 and begin deriving benefits from it. The study PI, Dr. Amy Krentzman, developed Positive Recovery Journaling (PRJ, formerly positive peer journaling) as a simple 10-minute daily practice which reviews the past 24 hours on the left side of a journal page and plans the upcoming 24 hours on the right side of a journal page. The prompts for the left and right sides of the PRJ page are based on principles from positive psychology and behavioral activation. The main objective of this study is to pilot test the PRJ intervention and to examine the feasibility, acceptability, and logistics of treatment delivery. A second objective is to observe whether PRJ is associated with improvement in satisfaction with life, happiness with recovery, and commitment to sobriety

Interventions

PPJ is a journaling practice to support addiction recovery. PPJ encourages past 24 hour review and upcoming 24 hour planning to improve subjective wellbeing in recovery and reduce relapse. PPJ uses journals with column headings under which individuals make bullet-pointed lists. On the left hand page, past 24 hours is recalled, itemizing good and bad things that happened and things for which one is grateful. Good wishes for others are also expressed on this page. On the right hand page, values-based activities for the upcoming 24 hours are planned via headings representing valued life domains such as recovery, work/school, spirituality, home and household, and health.

Sponsors

University of Minnesota
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* meet DSM-V criteria for past-year Substance Use Disorder as primary or secondary diagnosis, * English literacy sufficient to make short written lists needed to complete PPJ and homework assessments, * minimum 2 weeks sustained abstinence, * completed first 2 weeks of treatment at Nuway (approximately 2 weeks), an intensive outpatient substance use disorder treatment program and the recruitment site, * agree to be audio recorded or transcription recorded in group meetings and in individual meetings with research staff, * currently are clients in the Nuway outpatient program, * participants must be English speaking and literacy must be strong enough to write short lists and to understand the questions asked in the questionnaires, * participants must have an electronic device that connects to the internet and internet connection for online delivery of intervention during COVID-19.

Exclusion criteria

* presence of a psychotic disorder, psychiatric condition (e.g., suicidal ideation), or cognitive impairment (e.g., severe dementia, traumatic brain injury) limiting ability to give consent and/or participate in the study; * severe psychiatric illness (current schizophrenia, major depression with suicidal ideation); * personality disorders that would interfere with satisfactory participation in or completion of the study protocol, * inability to give informed, voluntary consent to participate, * lack of sufficient English literacy to participate, defined as inability to make a list of 5 things they did yesterday and inability to understand questionnaire items, * any impairment, activity, or situation that in the judgement of the research staff would prevent satisfactory participation in or completion of the study protocol.

Design outcomes

Primary

MeasureTime frameDescription
Satisfaction With Life at BaselineBaselineScore on the Satisfaction with Life scale. This scale has 5 items assessed on a 7 point Likert-type response format. Scores range from 5 to 35 with higher scores representing higher satisfaction with life.
Satisfaction With Life at 2 Weeks2 weeks (after Phase 1, the group phase)Score on the Satisfaction with Life scale. This scale has 5 items assessed on a 7 point Likert-type response format. Scores range from 5 to 35 with higher scores representing higher satisfaction with life.
Satisfaction With Life at 4 Weeks4 weeks (after Phase 2, the independent practice phase)Score on the Satisfaction with Life scale. This scale has 5 items assessed on a 7 point Likert-type response format. Scores range from 5 to 35 with higher scores representing higher satisfaction with life.
Satisfaction With Life at 8 Weeks8 weeks (the 1-month post-intervention)Score on the Satisfaction with Life scale. This scale has 5 items assessed on a 7 point Likert-type response format. Scores range from 5 to 35 with higher scores representing higher satisfaction with life.
Happiness With Recovery at BaselineBaselineScore on a single item, In general, I am happy with my recovery. This item uses an 11 point scale ranging from 0 to 10. Higher scores represent higher happiness with recovery.
Happiness With Recovery at 2 Weeks2 weeks (after Phase 1, the group phase)Score on a single item, In general, I am happy with my recovery. This item uses an 11 point scale ranging from 0 to 10. Higher scores represent higher happiness with recovery.
Happiness With Recovery at 4 Weeks4 weeks (after Phase 2, the independent practice phase)Score on a single item, In general, I am happy with my recovery. This item uses an 11 point scale ranging from 0 to 10. Higher scores represent higher happiness with recovery.
Happiness With Recovery at 8 Weeks8 weeks (the 1-month post intervention)Score on a single item, In general, I am happy with my recovery. This item uses an 11 point scale ranging from 0 to 10. Higher scores represent higher happiness with recovery.
Commitment to Sobriety at BaselineBaselineScore on a single item, I am willing to do whatever it takes to recover from my addiction. This item uses an 11 point scale ranging from 0-10. Higher scores represent greater commitment to sobriety.
Commitment to Sobriety at 2 Weeks2 weeks (after Phase 1, the group phase)Score on a single item, I am willing to do whatever it takes to recover from my addiction. This item uses an 11 point scale ranging from 0-10. Higher scores represent greater commitment to sobriety.
Commitment to Sobriety at 4 Weeks4 weeks (after Phase 2, the independent practice phase)Score on a single item, I am willing to do whatever it takes to recover from my addiction. This item uses an 11 point scale ranging from 0-10. Higher scores represent greater commitment to sobriety.
Commitment to Sobriety at 8 Weeks8 weeks (the 1-month post intervention)Score on a single item, I am willing to do whatever it takes to recover from my addiction. This item uses an 11 point scale ranging from 0-10. Higher scores represent greater commitment to sobriety.

Countries

United States

Participant flow

Participants by arm

ArmCount
Treatment Group
Participants in this group will complete the intervention, Positive Peer Journaling (PPJ), while also continuing to attend intensive outpatient treatment for addiction. Positive Peer Journaling (PPJ): PPJ is a journaling practice to support addiction recovery. PPJ encourages past 24 hour review and upcoming 24 hour planning to improve subjective wellbeing in recovery and reduce relapse. PPJ uses journals with column headings under which individuals make bullet-pointed lists. On the left hand page, past 24 hours is recalled, itemizing good and bad things that happened and things for which one is grateful. Good wishes for others are also expressed on this page. On the right hand page, values-based activities for the upcoming 24 hours are planned via headings representing valued life domains such as recovery, work/school, spirituality, home and household, and health.
42
Control Group
There will be no intervention for those randomized to the control group. However, they will complete assessment instruments throughout the study period while also continuing to attend intensive outpatient treatment for addiction.
39
Total81

Baseline characteristics

CharacteristicControl GroupTotalTreatment Group
Age, Continuous39.4 years
STANDARD_DEVIATION 10.4
39 years
STANDARD_DEVIATION 11
38.6 years
STANDARD_DEVIATION 11.7
Race (NIH/OMB)
American Indian or Alaska Native
2 Participants5 Participants3 Participants
Race (NIH/OMB)
Asian
1 Participants1 Participants0 Participants
Race (NIH/OMB)
Black or African American
1 Participants4 Participants3 Participants
Race (NIH/OMB)
More than one race
2 Participants9 Participants7 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants2 Participants1 Participants
Race (NIH/OMB)
White
32 Participants60 Participants28 Participants
Sex/Gender, Customized
Female
19 Participants43 Participants24 Participants
Sex/Gender, Customized
Male
19 Participants37 Participants18 Participants
Sex/Gender, Customized
Non Binary
1 Participants1 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 420 / 39
other
Total, other adverse events
0 / 420 / 39
serious
Total, serious adverse events
0 / 420 / 39

Outcome results

Primary

Commitment to Sobriety at 2 Weeks

Score on a single item, I am willing to do whatever it takes to recover from my addiction. This item uses an 11 point scale ranging from 0-10. Higher scores represent greater commitment to sobriety.

Time frame: 2 weeks (after Phase 1, the group phase)

Population: The Overall Number of Participants Analyzed reported here represents the study census for this outcome at 2 weeks. In the study flow section of this report, the values reported under completed represent the study census at 8 weeks. That is why the values reported here and the values reported in the study flow under completed do not match.

ArmMeasureValue (MEAN)Dispersion
Treatment GroupCommitment to Sobriety at 2 Weeks8.8 units on a scaleStandard Deviation 1.5
Control GroupCommitment to Sobriety at 2 Weeks9.1 units on a scaleStandard Deviation 1.7
Primary

Commitment to Sobriety at 4 Weeks

Score on a single item, I am willing to do whatever it takes to recover from my addiction. This item uses an 11 point scale ranging from 0-10. Higher scores represent greater commitment to sobriety.

Time frame: 4 weeks (after Phase 2, the independent practice phase)

Population: The Overall Number of Participants Analyzed reported here represents the study census for this outcome at 4 weeks. In the study flow section of this report, the values reported under completed represent the study census at 8 weeks. That is why the values reported here and the values reported in the study flow under completed do not match.

ArmMeasureValue (MEAN)Dispersion
Treatment GroupCommitment to Sobriety at 4 Weeks8.8 units on a scaleStandard Deviation 1.5
Control GroupCommitment to Sobriety at 4 Weeks8.9 units on a scaleStandard Deviation 1.8
Primary

Commitment to Sobriety at 8 Weeks

Score on a single item, I am willing to do whatever it takes to recover from my addiction. This item uses an 11 point scale ranging from 0-10. Higher scores represent greater commitment to sobriety.

Time frame: 8 weeks (the 1-month post intervention)

Population: The Overall Number of Participants Analyzed reported here represents the study census for this outcome at 8 weeks. These values match those reported as completed in the the study flow section of this report.

ArmMeasureValue (MEAN)Dispersion
Treatment GroupCommitment to Sobriety at 8 Weeks8.5 units on a scaleStandard Deviation 2.5
Control GroupCommitment to Sobriety at 8 Weeks8.6 units on a scaleStandard Deviation 2.1
Primary

Commitment to Sobriety at Baseline

Score on a single item, I am willing to do whatever it takes to recover from my addiction. This item uses an 11 point scale ranging from 0-10. Higher scores represent greater commitment to sobriety.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Treatment GroupCommitment to Sobriety at Baseline8.6 units on a scaleStandard Deviation 1.8
Control GroupCommitment to Sobriety at Baseline9.2 units on a scaleStandard Deviation 1.4
Primary

Happiness With Recovery at 2 Weeks

Score on a single item, In general, I am happy with my recovery. This item uses an 11 point scale ranging from 0 to 10. Higher scores represent higher happiness with recovery.

Time frame: 2 weeks (after Phase 1, the group phase)

Population: The Overall Number of Participants Analyzed reported here represents the study census for this outcome at 2 weeks. In the study flow section of this report, the values reported under completed represent the study census at 8 weeks. That is why the values reported here and the values reported in the study flow under completed do not match.

ArmMeasureValue (MEAN)Dispersion
Treatment GroupHappiness With Recovery at 2 Weeks8.3 units on a scaleStandard Deviation 1.8
Control GroupHappiness With Recovery at 2 Weeks8.6 units on a scaleStandard Deviation 1.9
Primary

Happiness With Recovery at 4 Weeks

Score on a single item, In general, I am happy with my recovery. This item uses an 11 point scale ranging from 0 to 10. Higher scores represent higher happiness with recovery.

Time frame: 4 weeks (after Phase 2, the independent practice phase)

Population: The Overall Number of Participants Analyzed reported here represents the study census for this outcome at 4 weeks. In the study flow section of this report, the values reported under completed represent the study census at 8 weeks. That is why the values reported here and the values reported in the study flow under completed do not match.

ArmMeasureValue (MEAN)Dispersion
Treatment GroupHappiness With Recovery at 4 Weeks8.4 units on a scaleStandard Deviation 2.2
Control GroupHappiness With Recovery at 4 Weeks8.4 units on a scaleStandard Deviation 1.9
Primary

Happiness With Recovery at 8 Weeks

Score on a single item, In general, I am happy with my recovery. This item uses an 11 point scale ranging from 0 to 10. Higher scores represent higher happiness with recovery.

Time frame: 8 weeks (the 1-month post intervention)

Population: The Overall Number of Participants Analyzed reported here represents the study census for this outcome at 8 weeks. These values match the values reported as completed in the study flow section of this report.

ArmMeasureValue (MEAN)Dispersion
Treatment GroupHappiness With Recovery at 8 Weeks8.2 units on a scaleStandard Deviation 2
Control GroupHappiness With Recovery at 8 Weeks8.3 units on a scaleStandard Deviation 2.4
Primary

Happiness With Recovery at Baseline

Score on a single item, In general, I am happy with my recovery. This item uses an 11 point scale ranging from 0 to 10. Higher scores represent higher happiness with recovery.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Treatment GroupHappiness With Recovery at Baseline8.1 units on a scaleStandard Deviation 1.9
Control GroupHappiness With Recovery at Baseline8.4 units on a scaleStandard Deviation 1.8
Primary

Satisfaction With Life at 2 Weeks

Score on the Satisfaction with Life scale. This scale has 5 items assessed on a 7 point Likert-type response format. Scores range from 5 to 35 with higher scores representing higher satisfaction with life.

Time frame: 2 weeks (after Phase 1, the group phase)

Population: The Overall Number of Participants Analyzed reported here represents the study census for this outcome at 2 weeks. In the study flow section of this report, the values reported under completed represent the study census at 8 weeks. That is why the values reported here and the values reported in the study flow under completed do not match.

ArmMeasureValue (MEAN)Dispersion
Treatment GroupSatisfaction With Life at 2 Weeks20.5 units on a scaleStandard Deviation 6.8
Control GroupSatisfaction With Life at 2 Weeks18.6 units on a scaleStandard Deviation 7.8
Primary

Satisfaction With Life at 4 Weeks

Score on the Satisfaction with Life scale. This scale has 5 items assessed on a 7 point Likert-type response format. Scores range from 5 to 35 with higher scores representing higher satisfaction with life.

Time frame: 4 weeks (after Phase 2, the independent practice phase)

Population: The Overall Number of Participants Analyzed reported here represents the study census for this outcome at 4 weeks. In the study flow section of this report, the values reported under completed represent the study census at 8 weeks. That is why the values reported here and the values reported in the study flow under completed do not match.

ArmMeasureValue (MEAN)Dispersion
Treatment GroupSatisfaction With Life at 4 Weeks19.4 units on a scaleStandard Deviation 7.5
Control GroupSatisfaction With Life at 4 Weeks18.8 units on a scaleStandard Deviation 7.9
Primary

Satisfaction With Life at 8 Weeks

Score on the Satisfaction with Life scale. This scale has 5 items assessed on a 7 point Likert-type response format. Scores range from 5 to 35 with higher scores representing higher satisfaction with life.

Time frame: 8 weeks (the 1-month post-intervention)

Population: The Overall Number of Participants Analyzed reported here represents the study census for this outcome at 8 weeks. These values match the values reported as completed in the study flow section of this report.

ArmMeasureValue (MEAN)Dispersion
Treatment GroupSatisfaction With Life at 8 Weeks21 units on a scaleStandard Deviation 7.4
Control GroupSatisfaction With Life at 8 Weeks21.2 units on a scaleStandard Deviation 7.9
Primary

Satisfaction With Life at Baseline

Score on the Satisfaction with Life scale. This scale has 5 items assessed on a 7 point Likert-type response format. Scores range from 5 to 35 with higher scores representing higher satisfaction with life.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Treatment GroupSatisfaction With Life at Baseline17.8 units on a scaleStandard Deviation 6.6
Control GroupSatisfaction With Life at Baseline17.2 units on a scaleStandard Deviation 6.4

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026